TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 91 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q3 2016. The put-call ratio across all filers is 0.41 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $1,733,000 | -82.5% | 452,375 | -80.3% | 0.44% | -84.4% |
Q2 2016 | $9,888,000 | -41.5% | 2,299,529 | -37.1% | 2.83% | -53.4% |
Q1 2016 | $16,914,000 | -13.1% | 3,653,200 | +88.3% | 6.07% | -25.7% |
Q4 2015 | $19,458,000 | +132.9% | 1,940,000 | +73.2% | 8.16% | +147.0% |
Q3 2015 | $8,355,000 | – | 1,120,000 | – | 3.30% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 330,000 | $2,353,000 | 0.98% |
EcoR1 Capital, LLC | 633,400 | $4,516,000 | 0.80% |
DLD Asset Management, LP | 570,000 | $4,059,000 | 0.53% |
Rhenman & Partners Asset Management AB | 300,000 | $2,139,000 | 0.31% |
Eventide Asset Management | 600,000 | $4,278,000 | 0.27% |
Tekla Capital Management LLC | 1,004,322 | $7,161,000 | 0.26% |
Rock Springs Capital Management LP | 698,000 | $4,977,000 | 0.25% |
DLD Asset Management, LP | 230,000 | $1,640,000 | 0.21% |
Worth Venture Partners, LLC | 29,325 | $209,000 | 0.18% |
Crestline Management, LP | 161,403 | $1,151,000 | 0.15% |